ANGO vs NVR · rev $292.5M vs P/E 15, rev $10.52B
AngioDynamics Inc (ANGO) versus NVR Inc (NVR) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
NVR Inc (NVR) is a residential construction company listed on NYSE.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
Latest reported NVR revenue for 2024-12-31 was $10.52B. Net income was $1.68B. Revenue was up 10.6% from 2023-12-31 to 2024-12-31. NVR currently screens at market cap $16.94B and trailing P/E 15.3.
ANGO currently screens at market cap $378.5M. NVR currently screens at market cap $16.94B and trailing P/E 15.3.
Not investment advice. Open the ANGO and NVR stock pages for the full models.
Not investment advice.